BioSpace News Archive

Today Dow will close the sale of its rail infrastructure assets at six North American sites; transaction to close three months earlier than planned and demonstrates best-owner mindset and continued evaluation of non-revenue-generating assets across its global portfolio

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that management will present at the following upcoming virtual investor conferences in October:

IGM Biosciences, Inc. announced that the first patient has been dosed in its Phase 1 clinical trial evaluating IGM-8444, an IgM antibody targeting the Death Receptor 5 protein, in patients with solid cancers and non-Hodgkin’s lymphoma.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a New Drug Application to the U.S. FDA for UPTRAVI® as an injection for intravenous use for the treatment of pulmonary arterial hypertension in adults with WHO functional class II–III, who are currently prescribed oral UPTRAVI but are temporarily unable to take oral therapy.

Ongoing Phase I/II trial to enroll up to 6 additional patients in Cohort 2 while planning for next steps in program; further trial updates expected by the end of 2020

First-Ever Study to Have Evaluated the Safety and Efficacy of an Investigational RNAi Therapeutic in Infants and Children Under the Age of Six

Medeor Therapeutics, Inc. announced that interim results from the company’s MERCURY Phase 3 clinical trial will be presented by lead Principal Investigator Dr. Dixon Kaufman of the University of Wisconsin at the American Society of Nephrology Kidney Week 2020, being held virtually from October 19-25, 2020.

Bruker Corporation announces the recent acquisition of the Integrated Proteomics Pipeline search engine and proteomics workflow software platform.

Winn-Dixie is partnering with American Cancer Society’s Making Strides Against Breast Cancer during the month of October to raise funds and spread hope to those impacted by breast cancer. Now through Nov. 3, customers in Alabama, Mississippi and Columbus, Georgia can help their neighbors fighting breast cancer by rounding

The death toll from COVID-19 passed one million this week. It is a sobering moment. But there is cause for optimism as recent days have seen a significant surge in momentum around global cooperation, which is our greatest strength when it comes to consigning this pandemic to the history books.